MALVERN, Pa. and COLUMBIA, Md, Sept. 15, 2021 — LifeScan, a world leader in blood
glucose monitoring, serving more than 20 million people with diabetes and the maker of the
iconic OneTouch® brand products, and Welldoc, a digital health leader revolutionizing chronic
care, today announced a strategic partnership to incorporate Welldoc’s chronic condition
platform, supporting hypertension, heart failure, diabetes, pre-diabetes and behavioral health,
into the new OneTouch® Solutions portal, designed to offer a choice of support, guidance and
digital tools to help people not just manage diabetes but thrive.
Diabetes doesn’t happen in isolation. Other chronic conditions are common among people with
diabetes. Studies suggest that most adults with diabetes have at least one comorbid chronic
disease and as many as 40 percent have at least three.¹ According to research, people with
multiple chronic conditions can need more frequent and varied interventions, across multiple
providers – this complexity can make self-management of care difficult. In fact, as an increased
number of care providers are required, these individuals can struggle to understand, remember,
and reconcile their healthcare needs.² The American Diabetes Association suggests that
collaborative, connected, multidisciplinary teams are best suited to facilitate self-management.³
“As a valued and long-standing partner, Welldoc shares in our commitment to help people with
diabetes manage their whole-health with meaningful and integrated solutions,” said Val Asbury,
LifeScan president and chief executive officer. “By adding Welldoc’s evidence-based platform
for pre-diabetes, diabetes, hypertension, heart failure and behavioral health with our OneTouch
digital solutions, we are leaning into our mission to deliver personalized health and wellness
experiences that engage people with diabetes and related conditions to live their best lives.”
“Welldoc’s cloud-based, digital-first offerings are an important part of the larger digital
ecosystem of connected solutions and services LifeScan is creating to help support a healthy
lifestyle for the millions of people with diabetes who count on OneTouch® products,” Asbury
said.
“Chronic conditions continue to present a global health and economic crisis,” said Kevin
McRaith, Welldoc president and chief executive officer. “Our scalable platform empowers
individuals to self-manage their conditions, enabling high quality, continuous connected care for
multiple chronic conditions. Our new partnership with LifeScan will help individuals living with
diabetes and other chronic conditions to simplify their journey, reduce their complexity of care
management and improve their outcomes.”
The Welldoc solution connects important health data across multiple conditions, all under one
platform. Welldoc’s advanced Artificial Intelligence (AI) leverages the power of this health data –
medications, labs, diet, activity, symptoms and psychosocial factors – to provide personalized,
real-time coaching.
Welldoc’s award-winning, FDA-cleared digital health solution, BlueStar®, powers LifeScan’s
current digital diabetes coaching solution, OneTouch Reveal® Plus, which is available through
select payer and employer plans.
OneTouch Solutions will be offered to consumers in the US starting this fall, and then offered to
healthcare providers and payors as a reimbursed adjudicated option in early 2022.
About the OneTouch® brand made by LifeScan
LifeScan is a global leader in blood glucose monitoring innovation and digital health technology
and has a vision to create a world without limits for people with diabetes and related conditions.
More than 20 million people and their caregivers around the world count on LifeScan’s
OneTouch brand products to manage their diabetes. Together, LifeScan and OneTouch
improve the quality of life for people with diabetes with products and digital platforms defined by
simplicity, accuracy, and trust. www.LifeScan.com and www.OneTouch.com
About Welldoc
Welldoc® , a digital health leader revolutionizing chronic care, is integrating personalized, real-
time and actionable insights into the daily lives of individuals living with chronic conditions,
enabling improved health and outcomes. Welldoc’s comprehensive chronic care platform
provides multi-condition support across diabetes, hypertension, heart failure and behavioral
health. Welldoc’s flagship product, BlueStar® , an FDA-cleared digital health solution, guides
individuals through the complicated journey of living with diabetes by enabling them to self-
manage their care while enhancing connections to their healthcare team. Welldoc partners with
health plans, health systems and employers with the goal of extending care, improving health
and reducing costs. For more information, visit www.welldoc.com.
Media Contacts:
Marc Boston – LifeScan
mboston@lifescan.com
Megan McGrath – Welldoc
mmcgrath@macbiocom.com
¹Piette JD, Kerr EA. The impact of comorbid chronic conditions on diabetes care. Diabetes Care. 2006 Mar;29(3):725-31. doi: 10.2337/diacare.29.03.06.dc05-2078. PMID: 16505540.
²Vogeli, C., Shields, A.E., Lee, T.A. et al. Multiple Chronic Conditions: Prevalence, Health Consequences, and Implications for Quality, Care Management, and Costs. J GEN INTERN MED 22, 391–395 (2007). https://doi.org/10.1007/s11606-007-0322-1
³ADA Standards of Medical Care for Diabetes 2020
